drugset / Trial / NCT00052637

Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer

NCT00052637

Non-randomizedOpen-labelDiagnostic

Summary

RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have bladder cancer.

Timeline

Start
2001-09
Primary completion
2002-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject hexaminolevulinate Small molecule Other